Global Biomaterial Market (2009-2014), biotech-market-reports.com

Posted on April 4, 2010.

Report Description

The biomaterials market is defined and explained through the introduction of biotechnology and advances in the understanding of human tissue compatibility. Developing from bio-inert materials to biodegradable materials, biomaterials are widely used in medical devices, tissue replacement, and surface coating applications. The major segments in biomaterials market are ceramics, metals, polymers, and composites. Biomaterials products are classified into orthopedic, cardiovascular, gastrointestinal, wound care, urology, plastic surgery, and others. Reconstructive surgery and orthobiologics are the dominant segments in orthopedic biomaterials market.

Biomaterials products had a market size of $25.5 billion in 2008, and the biomaterial device market size was $115.4 billion in the same year, and is expected to reach $252.7 billion in 2014. This massive revenue potential highlights the immense opportunity in the market. In the next five years, the biomaterials market is expected to grow at a CAGR of 15%.

Improved patient benefits form the most important factor stimulating market growth for biomaterials. The other market drivers are increase in aging population, rising awareness, shorter product approval time, and larger application area. However, the lack of tissue availability and proper reimbursement facilities are restraining the growth of the biomaterials market.

Improvement in fabrication technology and new product development at competitive prices will be the key to future market growth. The U.S. and Europe hold a major share of the global biomaterials market; while emerging economies such as China, India, Japan, Brazil, Russia, and Romania represent a high growth rate.

REPORT DESCRIPTION

This report uses the term biomaterials to refer to the materials used in the human body. The report segments the global biomaterial market as follows:

Biomaterials product market Orthopaedic, cardiovascular, gastrointestinal, wound care, plastic surgery, urological and others
Biomaterials ingredient market Metals, polymers, ceramics, composites
Biomaterials application market General, surgical appliances and supplies, surgical and medical instruments, dental products, electro-medical equipment, in-vitro diagnostic products, and other applications

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide more than 100 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides more than 50 company profiles for each of its sub-segments.

What makes our reports unique?

We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and a minimum of 50 micro markets, which are collectively exhaustive and mutually exclusive.
No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, ROW.
We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
Comprehensive market analysis for the following sectors:

Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
What are market estimates and forecasts; which markets are doing well and which are not?
Where are the gaps and opportunities; what is driving the market?
Which are the key playing fields? Which are the winning edge imperatives?
How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

Table of Content

1. CHAPTER ONE: INTRODUCTION
2. Chapter two: Summary
3. Chapter three: Market overview
3.1. Driving factor analysis of Global biomaterial market
3.2. Defining the global biomaterial market
3.3. DEFINING The biomaterial DEVICE MARKET
3.4. Market drivers of biomaterial market
3.4.1. new and improved technologies
3.4.2. Advances in understanding of elementary biocompatibility science
3.4.3. Large application area
3.4.4. Introduction of bio-absorbable biomaterial products
3.4.5. Rising awareness
3.4.6. Development of synthetic biomaterials for medical applications
3.4.7. increase in aging population
3.4.8. Medical insurance coverage
3.4.9. Recent development in biomaterial research
3.4.10. Heightened interest in personal healthcare
3.5. Market inhibitors
3.5.1. Lack of tissue availability
3.5.2. Lack of proper reimbursement facilities
3.6. Opportunities
3.6.1. Streamlining issues in partnerships
3.6.2. Market participation by smaller companies
3.6.3. Growing need for integrated and combined materials
3.6.4. Development of new intelligent materials with dynamic molecular functions
3.6.5. Emerging preference for minimally invasive surgery
4. Chapter four: biomaterial product market
4.1. Orthopedic biomaterial market
4.1.1. Market drivers
4.1.1.1. Product penetration
4.1.1.2. Increase in demand for orthopedic biomaterial products in spine surgery
4.1.1.3. Easy surgical procedures
4.1.2. Market inhibitors
4.1.2.1. Economic constraints
4.1.2.2. Increase in competition has led to lesser profit margin
4.1.3. Opportunities
4.1.3.1. Spinal treatment expected to be on the rise
4.1.4. Top player analysis of orthopedic biomaterial market
4.1.5. Orthopedic reconstructive
4.1.5.1. Market drivers
4.1.5.1.1. Availability of a wide range of products for specific application
4.1.5.1.2. New materials with improved properties are developed to create demand
4.1.5.2. Market inhibitors and opportunities
4.1.5.3. Top Players analysis in Orthopedic Reconstructive market
4.1.5.4. Artificial hip biomaterial market
4.1.5.4.1. Cemented prostheses biomaterial market
4.1.5.4.2. Uncemented prostheses biomaterial market
4.1.5.5. Artificial knee biomaterial market
4.1.5.5.1. Non-constraint implants
4.1.5.5.2. Semi-constraint implants
4.1.5.5.3. Constraint implants
4.1.6. Trauma biomaterial product market
4.1.6.1. Market Drivers
4.1.6.1.1. Sports and other accidents are fuelling the trauma market
4.1.6.1.2. Innovation is a growth factor in trauma market
4.1.6.1.3. Plate and screw systems are driving the growth
4.1.6.2. Top Players analysis of Trauma Orthopedic biomaterial market
4.1.7. Orthobiologics
4.1.7.1. Top player analysis of orthobiologics biomaterial market
4.1.7.2. DBM
4.1.7.3. Machined bone allografts
4.1.7.4. Non proprietary allografts
4.1.7.5. Synthetic bone substitute
4.1.7.6. Bone morphogenic protein (BMP)
4.1.7.7. Platelet concentrates
4.1.8. Sports medicine
4.1.8.1. Market Drivers
4.1.8.1.1. Varying characteristics of implants suit the needs of operative sports
4.1.8.1.2. Quick healing medicines boost growth
4.1.8.2. Top player analysis of sports medicine orthopedic biomaterial market
4.1.9. Bone cement
4.1.9.1. Market Drivers
4.1.9.1.1. Lesions can be eased using bone cements
4.1.9.1.2. Bone cements can be used with antibiotics
4.1.9.2. Inhibitors and opportunities
4.1.9.3. Top player analysis of bone cement orthopedic biomaterial market
4.1.10. Spinal
4.1.10.1. Drivers
4.1.10.1.1. Spinal treatment for younger patients on the rise
4.1.10.1.2. Motion preserving devices drives growth
4.1.10.2. Inhibitors
4.1.10.3. Opportunities
4.1.10.4. Top player analysis of spine orthopedic biomaterial market
4.1.10.5. Cervical
4.1.10.6. Lumbar
4.1.11. Dental
4.1.11.1. Drivers
4.1.11.1.1. Advantages of implants over dentures and bridges
4.1.11.1.2. Implants last lifelong
4.1.11.2. Inhibitors and opportunities
4.1.11.3. Top player analysis of dental orthopedic biomaterial market
4.1.11.4. Dental bone graft and substitute
4.1.11.5. Allograft
4.1.11.6. Xenograft
4.1.11.7. Synthetic dental bone graft and substitute market
4.1.11.8. Tissue regeneration
4.1.11.9. Dental membranes
4.2. Cardiovascular
4.2.1. drivers
4.2.1.1. Advancements in treatments
4.2.1.2. Rising number of obesity cases affecting the growth of the procedures that use these products
4.2.1.3. Increase in thrombosis and heart failure treatments drive growth
4.2.1.4. Vascular surgery market is growing with the uses of biomaterials
4.2.2. Inhibitors and opportunities
4.2.3. Top player analysis of cardiovascular biomaterials market
4.2.4. Cardiac pacemakers biomaterial market
4.2.4.1. Top player analysis of cardiac pacemaker cardiovascular biomaterial market
4.2.5. Implantable Cardioverter Defibrillator
4.2.5.1. Top player analysis of implantable cardioverter defibrillator cardiovascular biomaterial market
4.2.6. Cardiac Stent
4.2.6.1. Top player analysis of cardiac stents biomaterial market
4.2.7. Artificial heart valves
4.2.7.1. Top player analysis of artificial heart valve cardiovascular biomaterial market
4.2.8. Vascular Access devices
4.2.8.1. Market Drivers
4.2.8.1.1. Demand for advanced cardiac care in developing countries
4.2.8.1.2. Eliminates repeated needle sticks
4.2.8.2. Inhibitors and opportunities
4.2.8.3. Top player analysis of vascular access devices biomaterial market
4.2.9. Peripheral vascular grafts
4.3. Wound care products
4.3.1. drivers
4.3.1.1. Multiple advantages over conventional wound care products
4.3.1.2. Supports healing process of the skin
4.3.1.3. Advanced gel based products help accelerate the healing of wounds in special category of patients
4.3.1.4. Prevention of bacterial colonization on sutures
4.3.1.5. Reduction in the cost of hospitalization
4.3.1.6. Eliminates frequent change of dressings
4.3.1.7. Increase in Diabetes foot ulcer
4.3.2. Inhibitors
4.3.3. Opportunities
4.3.3.1. Increase in penetration of negative pressure wound therapy outside the U.S.
4.3.3.2. Introduction of more efficient and cost effective therapies
4.3.3.3. Usage of natural polymer biomaterials for stability in treatment
4.3.4. Top player analysis of wound care biomaterial market
4.3.5. Internal tissue sealant
4.3.5.1. Drivers
4.3.5.1.1. Technological advances
4.3.5.1.2. Wide range of applications and features
4.3.5.1.3. Faster healing
4.3.5.2. Top player analysis of internal tissue sealant wound care biomaterial market
4.3.5.3. Fibrin Sealants
4.3.5.4. Synthetic sealants
4.3.6. Surgical Hemostats
4.3.6.1. Market Drivers
4.3.6.1.1. New surgical hemostats provide improved control of bleeding
4.3.6.1.2. Reduces the need for frequent blood transfusions
4.3.6.2. Inhibitors and opportunities
4.3.6.3. Top player analysis of surgical hemostats market
4.3.6.4. Thrombin-based hemostats
4.3.6.5. Oxidized regenerated cellulose based topical hemostats
4.3.6.6. Gelatin-based hemostats
4.3.6.7. Combination hemostats
4.3.6.8. Collagen based hemostats
4.3.6.9. Autologous based hemostats
4.3.6.10. Polysaccharide based hemostats
4.3.7. Adhesion barriers
4.3.7.1. Drivers
4.3.7.1.1. Absorbable barriers are developed for surgeries
4.3.7.1.2. Reduces adhesion probability
4.3.7.2. Inhibitors and opportunities
4.3.7.3. Top player analysis of adhesion prevention wound care biomaterial market
4.3.7.4. Films
4.3.7.5. Gels
4.3.8. Skin substitutes
4.3.9. drivers
4.3.9.1. Increased incidences of gastro-intestinal diseases
4.3.9.2. FDA approval for shifting gastrointestinal drugs from prescription drugs to over-the-counter
4.3.10. Inhibitors
4.3.10.1. Lack of awareness of probiotic cultured materials
4.3.11. Opportunities
4.3.11.1. New developments coming up in gastrointestinal wound healing
4.3.12. Top player analysis of gastrointestinal biomaterial market
4.4. Urological market
4.4.1. drivers
4.4.1.1. Availability of biodegradable materials for treatment
4.4.1.2. Development of scaffolds for the treatment of several disorders
4.4.2. Inhibitors and Opportunities
4.4.3. Top player analysis of urological biomaterial market
4.4.4. Urological stents
4.4.4.1. Market Drivers
4.4.4.1.1. Stents are used in short duration treatment
4.4.4.1.2. Broad indications and growing population boost the market
4.4.4.2. Inhibitors and Opportunities
4.4.5. Urological catheters
4.4.5.1. Drivers
4.4.5.1.1. New approach in catheter design has set performance standards to increase demand
4.4.5.1.2. Increased applicability of catheters boost the market
4.4.5.2. Inhibitors
4.4.5.3. Opportunities
4.4.5.3.1. Use of biomaterials in catheters eliminates certain disadvantages
4.4.5.3.2. Biocompatibility of chemicals can be improved in catheters
4.4.5.4. Dialysis catheter
4.4.5.4.1. Top player analysis of dialysis catheter market
4.4.5.5. Hemodialysis catheter
4.4.5.6. Peritonial catheter
4.4.5.7. Urinary catheter
4.4.5.8. Indwelling catheter
4.4.5.9. External catheter
4.4.5.10. Intermittent catheter
4.5. Plastic surgery
4.5.1. Market Drivers
4.5.1.1. More surgeons are moving towards plastic surgery market from reconstructive procedures
4.5.1.2. Cultural factors boost the market growth
4.5.1.3. Baby boomers to boost the market growth
4.5.2. Market Inhibitors
4.5.2.1. Difficulties in treating craniofacial trauma
4.5.3. Opportunities
4.5.3.1. Market has not tapped men for facial surgeries
4.5.3.2. Development of advanced procedures for quick patient recovery
4.5.4. Top player analysis of plastic surgery biomaterial market
4.5.5. Breast Implants
4.5.5.1. Drivers
4.5.5.1.1. More refined procedures are available
4.5.5.1.2. Choices available for breast implants are wider
4.5.5.2. Inhibitors
4.5.5.3. Opportunities
4.5.5.3.1. Reduction in complications will be an opportunity
4.5.5.3.2. Safety issues need to be addressed
4.5.5.4. Top player analysis of breast implants biomaterial market
4.5.5.5. Saline filled implants
4.5.5.6. Silicone filled implants
4.5.6. Injectable fillers
4.5.6.1. Drivers
4.5.6.1.1. Anti-aging has driven the market growth
4.5.6.1.2. Permanent results can be achieved using fillers
4.5.6.2. Inhibitors
4.5.6.2.1. Allergy reaction and re-absorption is a concern in injectable fillers
4.5.6.3. Opportunities
4.5.6.3.1. FDA approval not needed for fat fillers
4.5.6.4.Top player analysis of injectable fillers biomaterial market
4.5.7. Facial Implants
4.5.7.1. Drivers
4.5.7.1.1. Iraq war increased the demand for facial implants
4.5.7.1.2. Faster recovery and surgery times
4.5.7.2. Inhibitors
4.5.7.3. Opportunities
4.5.7.4. Top player analysis of facial implants biomaterial market
4.6. Other biomaterials
5. Chapter five: Biomaterial market
5.1. Ceramics
5.1.1. Drivers
5.1.1.1. Low stress shielding
5.1.1.2. No disease transmission
5.1.1.3. Material supply is unlimited
5.1.2. Inhibitors and opportunities
5.1.3. Top player analysis of ceramics market
5.1.4. Bioinert ceramics
5.1.4.1. Drivers
5.1.4.1.1. Can be used for high strength applications
5.1.4.1.2. They show high chemical stability
5.1.4.2. Inhibitors
5.1.4.3. Opportunities
5.1.4.3.1. Alumina
5.1.4.3.2. Drivers
5.1.4.3.3. Inhibitors
5.1.4.3.4. Opportunities
5.1.4.4. Zirconia ceramic
5.1.4.4.1. Drivers
5.1.4.4.2. Inhibitors
5.1.4.4.3. Opportunities
5.1.4.5. Other bioinert ceramics market
5.1.5. Bioactive ceramics
5.1.5.1. Drivers
5.1.5.1.1. They help in bone formation
5.1.5.1.2. They bond with living bone tissue
5.1.5.1.3. Inhibitors and Opportunities
5.1.5.2. Bioglass
5.1.5.2.1. Drivers
5.1.5.2.2. Inhibitors
5.1.5.2.3. Opportunities
5.1.5.3. Other bioactive ceramics market
5.1.6. Biodegradable ceramics
5.1.6.1. Drivers
5.1.6.1.1. They are the least toxic of ceramics
5.1.6.1.2. The degradable rate can be tailored
5.1.6.2. Inhibitors and opportunities
5.1.6.3. Hydroxyapetite
5.1.6.3.1. Drivers
5.1.6.3.2. Inhibitors
5.1.6.3.3. Opportunity
5.1.6.4.Others biodegradable biomaterial market
5.2. Metals
5.2.1. Drivers
5.2.1.1. Balancing act of metallic biomaterials
5.2.1.2. Improved properties of metallic biomaterials
5.2.2. Inhibitors
5.2.3. Opportunities
5.2.3.1. Improvement in corrosion resistance
5.2.3.2. Introduction of new alloys
5.2.4. Top player analysis of metallic biomaterial market
5.2.5. Pure form metals
5.2.5.1. Titanium
5.2.5.2. Gold
5.2.5.3. Silver
5.2.5.4. Platinum
5.2.6. Alloys
5.2.6.1. Drivers
5.2.6.1.1. Availability of ore for biomaterials manufacture
5.2.6.1.2. Can be sterilized easily
5.2.6.2. Inhibitors and opportunities
5.2.6.3. Top player analysis of alloy biomaterial market
5.2.6.4. High Carbon Cobalt Chromium alloy
5.3. Polymers
5.3.1. Drivers
5.3.1.1. Biodegradable naturally
5.3.1.2. Compatibility in imaging
5.3.2. Inhibitors and opportunities
5.3.3. Top player analysis of polymer biomaterial market
5.3.4. Natural polymers
5.3.4.1. Drivers
5.3.4.1.1. They are safe for use
5.3.4.1.2. They work at a molecular level
5.3.4.2. Inhibitors and opportunities
5.3.4.3. Collagen Market
5.3.4.4. Chitosan
5.3.4.5. Alginate
5.3.4.6. Others natural polymers
5.3.5. Synthetic polymers
5.3.5.1. PLA/PGA
5.3.5.2. PTFE (polytetrafluoroethylene)
5.3.5.3. Other synthetic polymers
6. Chapter Six: Application market
6.1. General surgery
6.1.1. Drivers
6.1.1.1. Suturing has become easier with the synthetic biomaterials
6.1.1.2. Stringent requirements of surgeons are met by biomaterials
6.1.1.3. Biomaterials are used as adhesion prevention materials
6.1.2. Inhibitors
6.1.3. Opportunities
6.1.3.1. The development of a permanent solution for adhesion prevention
6.1.3.2. Properties of biomaterials can be improved to increase usage
6.2. Surgical Appliances and supplies
6.2.1. Drivers
6.2.1.1. Advanced materials for surgical appliances drives growth
6.2.1.2. Surgical advances in orthopedic and prosthetic applications
6.2.1.3. Increased healthcare spending by developed countries
6.2.1.4. Tissue engineering doesn’t have any side effects
6.2.1.5. Biomaterials are used to accelerate natural phenomena
6.2.2. Market Inhibitors
6.2.2.1. Reduced availability of outside capital
6.2.2.2. Tissue engineering may require reoperation
6.2.2.3. The process of approving is slow
6.2.3. Opportunities
6.2.3.1. Demographic factors will provide growth
6.2.3.2. Increase in export opportunities
6.2.3.3. Development of artificial organs in future
6.2.3.4. Treatment of sleep disorder is under investigation
6.3. Drug delivery applications
6.3.1. Drivers
6.3.1.1. Enabling properties of biomaterials drive growth
6.3.1.2. Most of the biomaterials are bio-absorbable
6.3.1.3. Quick and effective methods have been developed
6.3.2. Inhibitors
6.3.3. Opportunities
6.4. Dental products
6.4.1. Drivers
6.4.1.1. Biomaterials have wider dental applications
6.4.1.2. Risk of dental disease is set to increase
6.4.1.3. Improvement in polymers used for dental applications
6.4.2. Inhibitors
6.4.3. Opportunities
6.5. Surgical and Medical Instruments
6.5.1. Drivers
6.5.1.1. Breakthrough in innovations of surgical instruments drive growth
6.5.1.2. Availability of cheap surgical instruments
6.5.2. Inhibitors
6.5.3. Opportunities
6.6. Electro medical equipment application
6.6.1. Drivers
6.6.1.1. There is a substantial increase in the number of patients
6.6.1.2. Demand for efficient procedures and economies of scale
6.6.2. Inhibitors
6.6.2.1. Polymers used in the equipment are prone to release toxic agents
6.6.2.2. There is a possibility of electrical leakage
6.6.3. Opportunities
6.7. Other applications
7. Chapter Seven: Geographic Analysis of biomaterial market
8. Chapter eight: Company profiles
8.1. 3DM, Inc.
8.2. AdvanSource Biomaterials Corporation
8.3. Allergan Inc.
8.4. AlloSource
8.5. Alphatec Spine, Inc.
8.6. Amedica Corporation
8.7. Angiotech Pharmaceuticals, Inc.
8.8. ApaTech Ltd.
8.9. Artimplant AB
8.10. Biocoral, Inc.
8.11. BioInteractions Ltd.
8.12. Bioretec Ltd.
8.13. Bio Syntech Canada Inc.
8.14. Boston Scientific Corporation
8.15. Collagen Matrix, Inc.
8.16. Corin Group PLC
8.17. Covalon technologies
8.18. CryoLife Inc.
8.19. Davol, Inc.
8.20. Depuy Orthopaedics Inc.
8.21. ETEX Corporation
8.22. Forticell Bioscience, Inc.
8.23. Genzyme Biosurgery
8.24. Haemacure Corporation
8.25. Inion Oy
8.26. Integra Lifesciences Holdings Corp.
8.27. International Biocomposites Ltd.
8.28. Invibio Ltd.
8.29. ISTO Technologies, Inc.
8.30. Kensey Nash Corporation
8.31. Medtronic, Inc.
8.32. Mentor Corporation
8.33. MIV Therapeutics Inc.
8.34. Olympus Terumo Biomaterials Ltd.
8.35. Organogenesis, Inc.
8.36. Orthovita
8.37. Osteotech, Inc.
8.38. Pioneer Surgical Technology
8.39. Polymer Technology Group
8.40. Protein Polymer Technologies Inc.
8.41. RTI Biologics, Inc.
8.42. Smith & Nephew plc
8.43. Stryker Corporation
8.44. Synthes, Inc.
8.45. TEI Biosciences
8.46. TORNIER Inc.
8.47. Vygon S.A
8.48. W.L. Gore & Associates Inc.
8.49. Wright Medical Group, Inc.
8.50. Zimmer Holding, Inc.
9. Chapter nine: Patent analysis
Appendix
1. U.S. biomaterial product patents
2. Europe biomaterial product patents
3. Asia biomaterial product patents
4. U.S. biomaterial patents
5. Europe biomaterial patent
6. Asia biomaterial patents

Biomaterials Find Wide Usage in the Medical Devices Industry

The biomaterials market has grown at a CAGR of more than 8% in the past two years to reach a current market size of $28 billion. In the next five years, the market is expected to grow at a CAGR of 15%, riding high on new product developments. This highlights the many opportunities that this market offers in terms of revenues and market growth.

The major segments in biomaterials market are ceramics, metals, polymers, and composites. Biomaterials products are classified into orthopedic, cardiovascular, gastrointestinal, wound care, urology, plastic surgery, and others. Reconstructive surgery and orthobiologics are the dominant segments in orthopedic biomaterials market.

The biomaterials market is still in a growing phase, with about 100,000 heart valves, 200,000 pacemakers and 1 million orthopedic devices implanted worldwide every year. The U.S. and Europe hold a major share of the global biomaterials market; while emerging economies such as China, India, Japan, Brazil, Russia, and Romania represent a high growth rate.

Global biomaterials market by products, 2009

biomaterial

Source: MarketsandMarkets

Orthopedic biomaterials are expected to be the dominant segment in global biomaterials market with 38% market share, closely followed by cardiovascular biomaterials with 37%. The market growth for these two segments is driven mainly by the increase in ageing population in developed and developing countries. More than 20% of the global population in 2050 is expected to be over 60 years of age. The markets for wound care, plastic surgery, and urology applications are also expected to grow at a high rate. Regenerative treatments and biodegradable products hold the key for future investments.

The key players in the global biomaterials market are Boston Scientific, DePuy, Invibio, Medtronic Inc., Synthes Inc., and Zimmer. Agreements and collaborations, new product launches, and geographic expansion are the most popular strategies that the companies employ to combat competition. Our patent analysis indicates that the U.S. has the highest percentage (45%) of patents filed, followed by Europe with 36%. Also, in 2008, the number of patents registered in Asia increased from 8% to 16%.

Source : http://www.biotech-market-reports.com/

Share and Enjoy: